These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 29160909
1. Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: A single center experience. Choudhary NS, Saraf N, Saigal S, Gautam D, Rastogi A, Goja S, Bhangui P, Srinivasan T, Yadav SK, Soin A. Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29160909 [Abstract] [Full Text] [Related]
2. Living donor liver transplantation during the first 3 months of life. Kasahara M, Sakamoto S, Sasaki K, Uchida H, Kitajima T, Shigeta T, Narumoto S, Hirata Y, Fukuda A. Liver Transpl; 2017 Aug; 23(8):1051-1057. PubMed ID: 28220684 [Abstract] [Full Text] [Related]
5. Late-onset acute rejection after living donor liver transplantation. Akamatsu N, Sugawara Y, Tamura S, Keneko J, Matsui Y, Hasegawa K, Makuuchi M. World J Gastroenterol; 2006 Nov 07; 12(41):6674-7. PubMed ID: 17075982 [Abstract] [Full Text] [Related]
6. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Jain A, Demetris AJ, Kashyap R, Blakomer K, Ruppert K, Khan A, Rohal S, Starzl TE, Fung JJ. Liver Transpl; 2001 Jul 07; 7(7):623-30. PubMed ID: 11460230 [Abstract] [Full Text] [Related]
7. Everolimus Rescue Treatment for Chronic Rejection After Pediatric Living Donor Liver Transplantation: 2 Case Reports. Ueno T, Hiwatashi S, Saka R, Yamanaka H, Takama Y, Tazuke Y, Bessho K, Okuyama H. Transplant Proc; 2018 Nov 07; 50(9):2872-2876. PubMed ID: 30318104 [Abstract] [Full Text] [Related]
11. Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience. Hirata Y, Sanada Y, Urahashi T, Ihara Y, Yamada N, Okada N, Katano T, Otomo S, Ushijima K, Mizuta K. Transplant Proc; 2018 Nov 07; 50(1):60-65. PubMed ID: 29407332 [Abstract] [Full Text] [Related]
12. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. Favi E, Spagnoletti G, Salerno MP, Pedroso JA, Romagnoli J, Citterio F. Clin Transplant; 2013 Nov 07; 27(4):E359-67. PubMed ID: 23710603 [Abstract] [Full Text] [Related]
16. Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation. Rudzik KN, Schonder KS, Humar A, Johnson HJ. Clin Transplant; 2024 Jul 07; 38(7):e15402. PubMed ID: 39023099 [Abstract] [Full Text] [Related]
18. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C. Liver Transpl; 2005 Nov 07; 11(11):1395-402. PubMed ID: 16237691 [Abstract] [Full Text] [Related]